Results 101 to 110 of about 16,188 (197)

Is the long-term use of proton pump inhibitors safe? [PDF]

, 2004
Long-term use of proton pump inhibitors (PPIs) appears safe, resulting in no clinically relevant adverse effects (strength of recommendation: B, based on nonsystematic reviews, cohort studies, or low-quality randomized controlled trials).
Malaty, Wail, Mayer, Jill Byerly, Stigleman, Sue   +2 more
core  

Practical Strategies for Pharmacist Integration with Primary Care: A Workbook. [PDF]

, 2014
This workbook is a practical set of tips and resources to assist pharmacists in providing clinical pharmacy services to primary care providers and their patients.
Biddle, Michael A, Kennedy, Amanda G
core   +1 more source

Pharmacokinetic Profiles of Lansoprazole in Patients With Morbid Obesity Post‐Roux‐en‐Y Gastric Bypass Surgery

Clinical and Translational Science
Data on the effects of Roux‐en‐Y gastric bypass (RYGB) surgery on lansoprazole pharmacokinetics in morbidly obese patients are limited. This study aimed to evaluate the impact of RYGB surgery on the pharmacokinetic profile of lansoprazole in Thai ...
Suthep Udomsawaengsup, Sathienrapong Chantawibul, Naranon Boonyuen, Sarunnuch Panyavorakhunchai, Pattharasai Kachornvitaya, Wasu Wisanuyothin, Pittawat Somvanapanich, Warittha Lertwatthiphong, Napatsanan Tanathitiphuwarat, Pajaree Chariyavilaskul   +9 more
doaj   +1 more source

Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term low-dose aspirin therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial [PDF]

, 2011
Kentaro Sugano, Yasushi Matsumoto, Tsukasa Itabashi, Sumihisa Abe, Nobuhiro Sakaki, Kiyoshi Ashida, Yuji Mizokami, Tsutomu Chiba, Shigeyuki Matsui, Tatsuya Kanto, Kazuyuki Shimada, Shinichiro Uchiyama, Naomi Uemura, Naoki Hiramatsu   +13 more
core   +1 more source

An Exploratory Analysis of Pharmaceutical Price Disparities and Their Implications Among Six Developed Nations [PDF]

In our study of 43 drugs, prescription drug prices in several wealthy nations (Australia, Canada, France, Germany, and the U.K.) were much lower than in the U.S. on average, well below relative per capita GDP. There was relatively little difference among
Calfee, John E., DuPr�, Elizabeth, Villarreal, Mario   +2 more
core   +1 more source

Lansoprazole as a possible trigger of restless legs syndrome with suspected periodic limb movement disorder in a hemodialysis patient: a case report. [PDF]

CEN Case Rep
Nakata H, Nishiwaki K.
europepmc   +1 more source

Chemical constituents and anti-ulcer effects of a wild pear (Pyrus syriaca Boiss.): Phytochemical, histopathological and apoptotic approaches. [PDF]

PLoS One
Ahmed KA, Tawfeeq SN, Abdullah SS, Saleh GN, Jabbar AA, Algefare AI, Alfwuaires MA, Haydar Saber M, Zainel MA, Al-Qaisi TS, Alshehri AD, Alsharif HI, Alqaisi KM, Mahomoodally MF.   +13 more
europepmc   +1 more source

Potassium-competitive Acid Blockers Versus Proton Pump Inhibitors for Erosive Esophagitis: A Systematic Review and Network Meta-analysis. [PDF]

J Neurogastroenterol Motil
Chang JW, Jung DH, Son NH, Gwon S, Jeong DM, Huh CW.   +5 more
europepmc   +1 more source

Comparative efficacy and safety of potassium-competitive acid blockers and proton pump inhibitors for erosive esophagitis: a network meta-analysis of randomized controlled trials. [PDF]

EClinicalMedicine
Al Hayek M, Lucendo AJ, Barberio B, Yadlapati R, Nounou MV, Beshr MS, Gyawali CP, Chan WW, Salama AH, Elhadi M, Savarino EV, Laine L.   +11 more
europepmc   +1 more source

Potassium-competitive acid blockers and advances in the management of patients with acid-related diseases: a narrative review. [PDF]

Front Physiol
Qiao X, Li P.
europepmc   +1 more source